Literature DB >> 20145018

The mismatch repair system modulates curcumin sensitivity through induction of DNA strand breaks and activation of G2-M checkpoint.

Zhihua Jiang1, ShunQian Jin, Jack C Yalowich, Kevin D Brown, Baskaran Rajasekaran.   

Abstract

The highly conserved mismatch (MMR) repair system corrects postreplicative errors and modulates cellular responses to genotoxic agents. Here, we show that the MMR system strongly influences cellular sensitivity to curcumin. Compared with MMR-proficient cells, isogenically matched MMR-deficient cells displayed enhanced sensitivity to curcumin. Similarly, cells suppressed for MLH1 or MSH2 expression by RNA interference displayed increased curcumin sensitivity. Curcumin treatment generated comparable levels of reactive oxygen species and the mutagenic adduct 8-oxo-guanine in MMR-proficient and MMR-deficient cells; however, accumulation of gammaH2AX foci, a marker for DNA double-strand breaks (DSB), occurred only in MMR-positive cells in response to curcumin treatment. Additionally, MMR-positive cells showed activation of Chk1 and induction of G(2)-M cell cycle checkpoint following curcumin treatment and inhibition of Chk1 by UCN-01 abrogated Chk1 activation and heightened apoptosis in MMR-proficient cells. These results indicate that curcumin triggers the accumulation of DNA DSB and induction of a checkpoint response through a MMR-dependent mechanism. Conversely, in MMR-compromised cells, curcumin-induced DSB is significantly blunted, and as a result, cells fail to undergo cell cycle arrest, enter mitosis, and die through mitotic catastrophe. The results have potential therapeutic value, especially in the treatment of tumors with compromised MMR function.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20145018      PMCID: PMC2837109          DOI: 10.1158/1535-7163.MCT-09-0627

Source DB:  PubMed          Journal:  Mol Cancer Ther        ISSN: 1535-7163            Impact factor:   6.261


  45 in total

1.  MSH2 and MSH6 are required for removal of adenine misincorporated opposite 8-oxo-guanine in S. cerevisiae.

Authors:  T T Ni; G T Marsischky; R D Kolodner
Journal:  Mol Cell       Date:  1999-09       Impact factor: 17.970

2.  High doses of SN1 type methylating agents activate DNA damage signaling cascades that are largely independent of mismatch repair.

Authors:  Lovorka Stojic; Petr Cejka; Josef Jiricny
Journal:  Cell Cycle       Date:  2005-03-10       Impact factor: 4.534

Review 3.  DNA mismatch repair.

Authors:  Thomas A Kunkel; Dorothy A Erie
Journal:  Annu Rev Biochem       Date:  2005       Impact factor: 23.643

Review 4.  Induction of apoptosis by curcumin and its implications for cancer therapy.

Authors:  D Karunagaran; R Rashmi; T R Santhosh Kumar
Journal:  Curr Cancer Drug Targets       Date:  2005-03       Impact factor: 3.428

5.  Curcumin mediated apoptosis in AK-5 tumor cells involves the production of reactive oxygen intermediates.

Authors:  S Bhaumik; R Anjum; N Rangaraj; B V Pardhasaradhi; A Khar
Journal:  FEBS Lett       Date:  1999-08-06       Impact factor: 4.124

Review 6.  Repair of oxidative damage to nuclear and mitochondrial DNA in mammalian cells.

Authors:  D L Croteau; V A Bohr
Journal:  J Biol Chem       Date:  1997-10-10       Impact factor: 5.157

7.  Consumption of the putative chemopreventive agent curcumin by cancer patients: assessment of curcumin levels in the colorectum and their pharmacodynamic consequences.

Authors:  Giuseppe Garcea; David P Berry; Donald J L Jones; Raj Singh; Ashley R Dennison; Peter B Farmer; Ricky A Sharma; William P Steward; Andreas J Gescher
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-01       Impact factor: 4.254

Review 8.  Eukaryotic DNA mismatch repair.

Authors:  R D Kolodner; G T Marsischky
Journal:  Curr Opin Genet Dev       Date:  1999-02       Impact factor: 5.578

9.  Methylator-induced, mismatch repair-dependent G2 arrest is activated through Chk1 and Chk2.

Authors:  Aaron W Adamson; Dillon I Beardsley; Wan-Ju Kim; Yajuan Gao; R Baskaran; Kevin D Brown
Journal:  Mol Biol Cell       Date:  2005-01-12       Impact factor: 4.138

10.  Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers.

Authors:  M L Veigl; L Kasturi; J Olechnowicz; A H Ma; J D Lutterbaugh; S Periyasamy; G M Li; J Drummond; P L Modrich; W D Sedwick; S D Markowitz
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

View more
  13 in total

1.  Curcumin and NCLX inhibitors share anti-tumoral mechanisms in microsatellite-instability-driven colorectal cancer.

Authors:  William Raoul; Thierry Lecomte; Maxime Guéguinou; Sajida Ibrahim; Jérôme Bourgeais; Alison Robert; Trayambak Pathak; Xuexin Zhang; David Crottès; Jacques Dupuy; David Ternant; Valérie Monbet; Roseline Guibon; Hector Flores-Romero; Antoine Lefèvre; Stéphanie Lerondel; Alain Le Pape; Jean-François Dumas; Philippe G Frank; Alban Girault; Romain Chautard; Françoise Guéraud; Ana J García-Sáez; Mehdi Ouaissi; Patrick Emond; Olivier Sire; Olivier Hérault; Gaëlle Fromont-Hankard; Christophe Vandier; David Tougeron; Mohamed Trebak
Journal:  Cell Mol Life Sci       Date:  2022-05-08       Impact factor: 9.261

Review 2.  Epigenetics/epigenomics and prevention by curcumin of early stages of inflammatory-driven colon cancer.

Authors:  Renyi Wu; Lujing Wang; Ran Yin; Rasika Hudlikar; Shanyi Li; Hsiao-Chen D Kuo; Rebecca Peter; Davit Sargsyan; Yue Guo; Xia Liu; A N Kong
Journal:  Mol Carcinog       Date:  2019-12-09       Impact factor: 4.784

3.  GADD45α modulates curcumin sensitivity through c-Abl- and JNK-dependent signaling pathways in a mismatch repair-dependent manner.

Authors:  Hemanth Naick; Shunqian Jin; R Baskaran
Journal:  Mol Cell Biochem       Date:  2016-01-30       Impact factor: 3.396

4.  A study of deregulated MMR pathways and anticancer potential of curcuma derivatives using computational approach.

Authors:  Priyanjali Bhattacharya; Trupti N Patel
Journal:  Sci Rep       Date:  2021-05-12       Impact factor: 4.379

5.  Curcumin chemosensitizes 5-fluorouracil resistant MMR-deficient human colon cancer cells in high density cultures.

Authors:  Mehdi Shakibaei; Constanze Buhrmann; Patricia Kraehe; Parviz Shayan; Cora Lueders; Ajay Goel
Journal:  PLoS One       Date:  2014-01-03       Impact factor: 3.240

6.  The role of reactive oxygen species and subsequent DNA-damage response in the emergence of resistance towards resveratrol in colon cancer models.

Authors:  D J Colin; E Limagne; K Ragot; G Lizard; F Ghiringhelli; É Solary; B Chauffert; N Latruffe; D Delmas
Journal:  Cell Death Dis       Date:  2014-11-20       Impact factor: 8.469

7.  Passively Targeted Curcumin-Loaded PEGylated PLGA Nanocapsules for Colon Cancer Therapy In Vivo.

Authors:  Rebecca Klippstein; Julie Tzu-Wen Wang; Riham I El-Gogary; Jie Bai; Falisa Mustafa; Noelia Rubio; Sukhvinder Bansal; Wafa T Al-Jamal; Khuloud T Al-Jamal
Journal:  Small       Date:  2015-07-03       Impact factor: 13.281

8.  Curcumin-induced mitotic arrest is characterized by spindle abnormalities, defects in chromosomal congression and DNA damage.

Authors:  Louise M Blakemore; Christoph Boes; Rebecca Cordell; Margaret M Manson
Journal:  Carcinogenesis       Date:  2012-11-03       Impact factor: 4.944

9.  Genistein abrogates G2 arrest induced by curcumin in p53 deficient T47D cells.

Authors:  Puji Astuti; Esti D Utami; Arsa W Nugrahani; Sismindari Sudjadi
Journal:  Daru       Date:  2012-11-30       Impact factor: 3.117

10.  bis-Dehydroxy-Curcumin triggers mitochondrial-associated cell death in human colon cancer cells through ER-stress induced autophagy.

Authors:  Valentina Basile; Silvia Belluti; Erika Ferrari; Chiara Gozzoli; Sonia Ganassi; Daniela Quaglino; Monica Saladini; Carol Imbriano
Journal:  PLoS One       Date:  2013-01-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.